期刊文献+

三维适形放疗治疗肺癌的应用效果与安全性观察 被引量:2

Effect and safety of three-dimensional conformal radiotherapy in the patients with pulmonary carcinoma
下载PDF
导出
摘要 目的:观察探讨三维适形放疗治疗肺癌的应用效果与安全性。方法:选取本院收治的70例非小细胞肺癌患者为研究对象,随机分为对照组(常规放疗组)35例和观察组(三维适形放疗组)35例,然后将两组的近期疗效、放疗后不同时间的放射性肺炎总发生率及治疗前后的FACT-L量表评分进行比较。结果:观察组治疗后的近期疗效优于对照组,放疗后不同时间的放射性肺炎总发生率低于对照组,且治疗后的FACT-L量表评分也均优于对照组,差异具有统计学意义(P<0.05)。结论:三维适形放疗在肺癌患者中的应用效果较好,且安全性较高,对于患者生存质量的改善发挥着积极的临床作用。 Objective. To observe and investigate the effect and safety of three-dimensional confor- mal radiotherapy in the patients with pulmonary carcinoma. Methods. Totally 70 patients with nonsmall- cell lung cancer in our hospital were enrolled and randomly divided into control group(conventional radio- theraphy group, n=35 cases) and observation group(three-dimensional conformal radiotherapy group, n= 35 cases),then the short term effect,the total rates of radiation pneumonitis at different time after the ra diotherapy and FACT-L score before and after the treatment of two groups were compared. Results:The short-term effect of observation group were better than those of control group, the total rates of radiation pneumonitis at different time after the radiotherapy were lower than those of control group,FACT-I, score after the treatment were all better than those of control group (P^0.05) all showing significant differ ences. Conclusion- Three-dimensional conformal radiotherapy shows better effects in the patients with pul- monary carcinoma, and it's safer, so it plays an active role in improving the life quality of patients.
出处 《海南医学院学报》 CAS 2014年第4期494-496,500,共4页 Journal of Hainan Medical University
基金 辽宁省卫生厅技术推广基金(c2271323)~~
关键词 三维适形放疗 肺癌 应用效果 安全性 Three-dimensional conformal radiotherapy Pulmonary carcinoma Application effect Safety
  • 相关文献

参考文献10

二级参考文献71

  • 1李承军,徐利明.肺癌放疗中活动靶区常规CT定位和PET/CT定位的模体研究比较[J].中国医学物理学杂志,2011,28(4):2743-2749. 被引量:8
  • 2田军,施瑞浩,江涛,曾昭冲,张新,白春学.45例肺癌脑转移放射治疗后生存期的影响因素[J].中国癌症杂志,2006,16(4):310-312. 被引量:12
  • 3谷铣之,殷蔚伯,余子豪,等.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2008:573.
  • 4Vokes EE, Hemdon JE 2nd, Kelley MJ, et al. Induction chem-otherapy followed by chemoradiotherapy compared with chemora-diotherapy alone for regionally advanced unresectable stage HINon-small-cell lung cancer: Cancer and Leukemia Group B[J]. J Clin Oncol, 2007,25(13) : 1698 -1704.
  • 5Zinner RG, Komaki R, Cox JD, et al. Dose escalation of gem-citabine is possible with concurrent chest three-dimensionalrather than two-dimensional radiotherapy : a phase I trial inpatients with stage IE non-small-cell lung cancer [ J]. Int J Ra-dial Oncol Biol Phys, 2009, 73 (1 ) : 119 - 127.
  • 6Price KA,Azzoli CG,Gaspar LE. Chemoradiation for unresectable stageDI non-small cell lung cancer[ J]. Semin Thorac Cardiovasc Surg,2008;20(3):204-9.
  • 7Hansen 0 ,Paarup H,Sorensen P,ei al. Curative radiotherapy of local ad-vanced non-small-cell lung cancer:eight years of experience from Odense[J]. Ugeskr Laeger,2005;167(37):3497-502.
  • 8Kong FP,Ten Haken J,Hayman N,et al.Personalized high dose radiation (>70 Gy)is significant associated with better local regional control and overall survival in non-small cell lung cancer treated with concurrent chemoradiation[J].Int J Radiat Oncol Biol Phys,2011,81(2):S594.
  • 9Ruysscher DD,Elmpt WV,Lambin P,et al.Radiotherapy with curative intent for lung cancer:A continuing success story[J].Radiother Oncol,2011,101:237.
  • 10Vogelius I S,Bentzen S.Clinical factors associated with risk of radiation pneumonitis:a litterature based meta-analysis[J].Radiotherapy and Oncology,2010,96(supp):125.

共引文献48

同被引文献22

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部